Glenn J. Hanna
6 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Toripalimab With Chemotherapy for Sinus Cancer (NCT06940180) | Glenn J. Hanna | 2025-06-17 |
| A Phase 2 Trial of Ivonescimab for Patients With Advanced, Metastatic Salivary Gland Cancers (NCT06805617) | Glenn J. Hanna | 2025-02-26 |
| Phase II Study of RP2 as Immunoprevention in High-Risk Oral Precancerous Disease (NCT06623110) | Glenn J. Hanna | 2025-01-01 |
| CB-103 With Either Lenvatinib or Abemaciclib in Patients With NOTCH ACC (NCT05774899) | Glenn J. Hanna | 2023-06-01 |
| Duvelisib Plus Docetaxel In Recurrent/Metastatic HNSCC (NCT05057247) | Glenn J. Hanna | 2021-10-14 |
| 9-ING-41 Plus Carboplatin in Salivary Gland Carcinoma (NCT05010629) | Glenn J. Hanna | 2021-09-17 |
Track Glenn J. Hanna automatically
Every clearance here is in the API, with alerts when new ones post.